SEC Form 4 · accession 0001144204-17-002474
BIOHITECH GLOBAL, INC. · BHTG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Frank E. Celli
Officer — Chief Executive Officer · Director · 10% Owner
Period of report
Jan 13, 2017
Accepted (ET)
Jan 17, 2017 · 5:18 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001590383
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Convertible Promissory NoteF3,F1,F2 | $2.75 | Jan 13, 2017 | X | 1 | A | Jan 13, 2017 | Jan 13, 2019 | Common Stock | 90,910 | 1 | D |
| WarrantsF5,F3,F4 | $3.30 | Jan 13, 2017 | X | 90,910 | A | Jan 13, 2017 | Jan 13, 2022 | Common Stock | 90,910 | 90,910 | D |
Explanation of responses
- F1Represents the highest possible conversion price of the note.
- F2Represents the number of shares of common stock, par value $0.001 per share (the "Common Stock") into which the note is convertible based on the conversion price of $2.75 per share. The note is convertible into an indeterminable number of shares.
- F3Does not include: 1,293,685 shares of common stock held by the reporting person; 506,667 shares of common stock underlying convertible debentures in the principal amount of $1,900,000 at the highest possible conversion price of $3.75 per share; or warrants to purchase an additional 506,667 shares of common stock held by the reporting person. The note and warrants are currently convertible into an indeterminable number of shares of common stock.
- F4Based upon 120% of the conversion price of $2.75 per share. The warrants are exercisable into an indeterminable number of shares.
- F5Represents the number of shares of Common Stock into which the warrants are exercisable based on the exercise price of $3.30 per share.